RB Capital Management’s Allergan plc AGN.PRA Stock Holding History

RB Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-482	Closed	-$283K	–	143
2017 Q4	$283K	Sell	482 -100	-17%	-$64.5K	0.2%	96
2017 Q3	$429K	Hold	582	–	–	0.34%	69
2017 Q2	$505K	Buy	582 +6	+1%	+$5.03K	0.44%	57
2017 Q1	$489K	Buy	576 +15	+3%	+$12.4K	0.46%	56
2016 Q4	$428K	Buy	+561	New	+$424K	0.43%	60

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

RB Capital Management's AGN.PRA Position: Q1 2018 in Review

RB Capital Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 482 shares — an estimated $283K sold.

RB Capital Management first reported a position in AGN.PRA in Q4 2016 and held it in 5 quarters. The position peaked at $505K in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

RB Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
RB Capital Management sold 482 Allergan plc shares in Q1 2018, an estimated $283K.
RB Capital Management first reported a position in Allergan plc in Q4 2016 and held it in 5 quarters.
RB Capital Management's Allergan plc position peaked at $505K in Q2 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on RB Capital Management's 13F filing for Q1 2018, filed 19 Apr 2018.